Financials

  • Market Capitalization 68.9 M
  • Employee 88
  • Founded 2005
  • CEO N/A
  • Website www.xbiotech.com
  • Headquarter British Columbia, Canada
  • FIGI BBG0081S8D39
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
2.78
Price to sales ratio
11.3
Dividends per share
Dividend yield %

XBiotech Inc

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

Новости